Articles by G. Steven Burrill - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by G. Steven Burrill

G. Steven Burrill


Chief Executive Officer at Burrill & Company

Articles
Moving the Needle on Healthcare
July 1, 2014

Gene therapy, immune-oncology, and digital healthcare technologies offer investors promise for innovation investments.

Biotech IPOs on a Hot Streak
April 1, 2014

Life-sciences companies continue upward momentum in 2014.

Life-Sciences IPOs Take a Breather
January 1, 2014

Frenzy cools as investors seeking a quick return turn elsewhere.

Robust IPO Market for Life Sciences Sparks Change Among Investors
October 1, 2013

Early-stage companies are now embraced by buyers of new issues.

IPO Market Heats Up for Life-Sciences Companies
July 1, 2013

Biotech companies raise most money in 13 years.

Financing Innovation
April 1, 2013

Early-stage companies are finding alternatives to venture capital.

Accelerating Change Marks 2012 for Life Sciences
January 1, 2013

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Recent Therapeutics IPOs Outshine Market, but Performance Mixed for Broader Life-Sciences Issues
October 1, 2012

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Pharmaceutical Dealmaking Broadens its Partnering Base
July 1, 2012

Collaborative R&D models coincide with new ways to fund translational research.

ADVERTISEMENT

ADVERTISEMENT

Click here